BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Multispan, Inc. Announces Licensing Agreement With Medarex, Inc. (MEDX)


10/12/2006 1:22:51 PM

HAYWARD Calif., Oct. 12 /PRNewswire/ -- Multispan Inc., an emerging San Francisco Bay Area biotechnology company, announced today a license agreement with Medarex, Inc., a leader in the discovery and development of therapeutic fully human monoclonal antibodies. Multispan will provide HEx(TM) G-protein Coupled Receptor (GPCR) over-expressing cell lines for use as whole cell immunogens by Medarex. Specific targets and financial details were not disclosed.

"We are excited to be working with Medarex," said Helena Mancebo, Multispan's founder and Chief Executive Officer. "We believe GPCRs represent a largely unexplored area for therapeutic antibody development and have confidence that the combination of our high expression cell lines and Medarex's proven, fully-human, antibody generation capability could lead to new antibody based treatments for important diseases."

Multispan Inc. is a San Francisco Bay Area-based biotechnology company focused exclusively on GPCRs, a most important protein class of therapeutic targets. Privately held, and founded in 2004, Multispan has created the industry's largest collection of human GPCR clones and has engineered a large collection of GPCR-expressing cell lines, including the proprietary HEx(TM) series of High Expression cell lines.

For further information, please visit the Multispan website (www.multispaninc.com) or contact Helena Mancebo (helena.mancebo@multispaninc.com).

Multispan Inc.

CONTACT: Helena Mancebo of Multispan Inc., +1-510-887-0817, ext. 101, orhelena.mancebo@multispaninc.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES